KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition

BACKGROUND: To study the molecular mechanism regulating sensitivity to MEK inhibition in pancreatic cancer cell lines. METHODS: A growth inhibition assay determined sensitivity to MEK162 in a panel of 29 pancreatic cancer cell lines. For the same panel, KRAS mutational status and copy-number variati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamidi, H, Lu, M, Chau, K, Anderson, L, Fejzo, M, Ginther, C, Linnartz, R, Zubel, A, Slamon, D J, Finn, R S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453732/
https://www.ncbi.nlm.nih.gov/pubmed/25167228
http://dx.doi.org/10.1038/bjc.2014.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453732/
https://www.ncbi.nlm.nih.gov/pubmed/25167228
http://dx.doi.org/10.1038/bjc.2014.475

Ejemplares similares